Searched for
ACTAVIS PHARMA MANUFACTURING LTD
Intas & Dr Reddy's in race with PEs to buy US' AthenexAthenex, which is into the development of cell therapies to treat cancers, had hired investment advisory firm Cowen Inc to run a formal pro...
Top domestic pharma companies in US probe for price-fixingDomestic majors — including Sun Pharma, Lupin and Aurobindo Pharma — along with US biggies Sandoz, Pfizer and Mylan have been charged with ...
Aurobindo buys US units of Sandoz for $900 millionThe acquired business has been carved out by the management of Sandoz for divestment.
Aurobindo Pharma to buy Portugal's Generis for 135 mn euroAurobindo Pharma has inked an agreement through its subsidiary Agile Pharma BV Netherlands to acquire Generis Farmaceutica.
Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players clubWith the acquisition of Teva’s products, sold through erstwhile Actavis’ operations, Intas is set to emerge as a top player in the UK gener...
Glenmark Pharma gets USFDA nod for two generic drugsQuoting IMS data, Glenmark Pharma said the approved product has an estimated market size of $74.1 million for the 12 months ended November ...
Aurobindo, Actavis recall Gabapentin capsulesThe drug is manufactured by Aurobindo Pharma at its Mahabub Nagar facility in Andhra Pradesh.
Aurobindo Pharma eyes $2 billion revenues in FY15The consolidated revenue (net) from operations was higher over the previous year by 38.3 per cent at nearly Rs 8,100 crore during 2013-14.
Sun Pharma to buy Ranbaxy in $3.2 bn deal“This is the biggest deal we have done, but not the most difficult one,” said Sun Pharma chairman Dilip Shanghvi.
Glenmark in talks to sell oral contraceptive unitThe company promoted by Glenn Saldanha has begun talks with some of the leading local and global drugmakers.
Vivimed acquires Actavis Pharma's facility for Rs 122 croreVivimed Labs today said it has acquired a manufacturing facility of Actavis Pharma Manufacturing Ltd for a total consideration of Rs 122 cr.
- US court bans Sun from selling Eloxatin: Sanofi Aventis
French drug maker Sanofi Aventis SA on Friday said a New Jersey US district court ordered Sun Pharma to stop selling its generic version of...
- Regenix beefs Board, goes for out-of-court settlement with Strides
Regenix promoter Dr A Ramamurthy made waves in the pharma circuit in 2007. That was when the physician-entrepreneur sold the marketing righ...
- Pfizer charges Sun with another patent violation
A legal battle between Pfizer and Sun Pharmaceutical has escalated.
- Small firms all set to pep up pharma retail
Organised pharma retail, dominated by the likes of Apollo and Subiksha, is set for more action at the regional level.
- TEVA TO buy local unit for Rs 400 cr
The world’s largest generic drug manufacturer Teva may be close to acquiring domestic company Saraca Labs’ manufacturing plant in Hyderabad...
- Cipla, PEs team up for Merck's biz
Ranbaxy Lab, Teva Corp, Actavis and Mylan are among the cos short listed in the first round.
- Actavis acquires Sanmar subsidiary
Actavis Group, the global generic pharma company, has announced the acquisition of the Active Pharmaceutical Ingredient (API).
- Cos exit generics for core focus
As international generics drug markets reel under increasing pricing pressure and ever-rising competition, big pharma companies are selling...
- Actavis acquires Grandix manufacturing plant
Actavis Group, an international generic pharmaceuticals company has acquired the three-year-old manufacturing factory of Chennai-based Gran...